Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylitol Topical Irrigation for Recalcitrant Chronic Sinusitis
NCT03229551Phase 3Completed
- Sponsor
- Ochsner Clinic Foundation
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of xylitol in chronic rhinosinusitis (CRS), sponsored by Ochsner Clinic Foundation. Primary endpoint: Effect of topical xylitol therapy on biofilm production at 3 months. Started Mar 2018; status: completed.
02
Drugs
xylitol
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03229551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229551.